A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer
| Autor: | Reck, M. *, Kaiser, R., Eschbach, C., Stefanic, M., Love, J., Gatzemeier, U., Stopfer, P., von Pawel, J. |
|---|---|
| Zdroj: | In Annals of Oncology June 2011 22(6):1374-1381 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|